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PQUARTERLY FOCUS ISSUE: HEART FAILURE
Natural History and Expansive Clinical
Profile of Stress (Tako-Tsubo) Cardiomyopathy
Scott W. Sharkey, MD,* Denise C. Windenburg, BA,* John R. Lesser, MD,* Martin S. Maron, MD,†
Robert G. Hauser, MD,* Jennifer N. Lesser,* Tammy S. Haas, RN,* James S. Hodges, PHD,‡
Barry J. Maron, MD*
Minneapolis, Minnesota; and Boston, Massachusetts
Objectives This study was designed to define more completely the clinical spectrum and consequences of stress cardiomy-
opathy (SC) beyond the acute event.
Background Stress cardiomyopathy is a recently recognized condition characterized by transient cardiac dysfunction with ven-
tricular ballooning.
Methods Clinical profile and outcome were prospectively assessed in 136 consecutive SC patients.
Results Patients were predominantly women (n  130; 96%), but 6 were men (4%). Ages were 32 to 94 years (mean
age 68  13 years); 13 (10%) were 50 years of age. In 121 patients (89%), SC was precipitated by intensely
stressful emotional (n  64) or physical (n  57) events, including 22 associated with sympathomimetic drugs
or medical/surgical procedures; 15 other patients (11%) had no evident stress trigger. Twenty-five patients
(18%) were taking beta-blockers at the time of SC events. Three diverse ventricular contraction patterns were
defined by cardiovascular magnetic resonance (CMR) imaging, usually with rapid return to normal systolic func-
tion, although delayed 2 months in 5%. Right and/or left ventricular thrombi were identified in 5 patients (pre-
dominantly by CMR imaging), including 2 with embolic events. Three patients (2%) died in-hospital and 116
(85%) have survived, including 5% with nonfatal recurrent SC events. All-cause mortality during follow-up ex-
ceeded a matched general population (p  0.016) with most deaths occurring in the first year.
Conclusions In this large SC cohort, the clinical spectrum was heterogeneous with about one-third either male, 50 years of
age, without a stress trigger, or with in-hospital death, nonfatal recurrence, embolic stroke, or delayed normal-
ization of ejection fraction. Beta-blocking drugs were not absolutely protective and SC was a marker for in-
creased noncardiac mortality. These data support expanded management and surveillance strategies including
CMR imaging and consideration for anticoagulation. (J Am Coll Cardiol 2010;55:333–41) © 2010 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.08.057s
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ptress (tako-tsubo) cardiomyopathy (SC) is a rapidly revers-
ble form of acute heart failure reported to be triggered by
tressful events and associated with a distinctive left ven-
ricular (LV) contraction pattern. Whereas the presentation
f SC has been described by several investigators (1–7),
here is a paucity of data from large and prospectively
dentified patient cohorts studied for extended periods of
ime following the initial event. Therefore, we assembled a
rom the *Hypertrophic Cardiomyopathy Center and Cardiovascular Research
ivision, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota; †Divi-
ion of Cardiology, Tufts Medical Center, Boston, Massachusetts; and the ‡Division
f Biostatistics, University of Minneapolis, Minneapolis, Minnesota. Supported in
art by a grant from The Hearst Foundations, San Francisco, California. Dr. John
esser receives speaker fees from Siemens and is on the scientific advisory board of
ital Images. Dr. Barry Maron is a consultant with GeneDX.t
Manuscript received May 8, 2009; revised manuscript received July 24, 2009,
ccepted August 20, 2009.ubstantial and consecutive group of patients with SC from
single institution to define more completely the broad
linical spectrum and long-term consequences of this re-
ently recognized condition.
ethods
atient population. Between August 2001 and Novem-
er 2008, 136 consecutive patients presented with SC to the
mergency and hospital facilities of the Minneapolis Heart
nstitute and Abbott Northwestern Hospital (Minneapolis,
innesota). The first 22 patients identified formed the
asis for our initial SC report (1). These patients are now
ncluded in the present study group of 136 patients, now
ith extended follow-up. Patients shared the following
iagnostic profile: 1) an acute cardiac event typically
resenting with substernal chest pain; 2) systolic dysfunc-
ion with marked LV contraction abnormality, extending
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of a single epicardial coronary
artery, assessed with LV angiog-
raphy, cardiovascular magnetic
resonance (CMR) imaging, or 2-
dimensional echocardiography;
and 3) absence of obstructive ath-
erosclerotic coronary artery steno-
sis (i.e., 50% luminal narrow-
ing of the epicardial arteries by
angiography).
The clinical status of surviving
study patients was assessed as of
ovember 1, 2008, by telephone interview, clinic visit, and/or
edical records. Follow-up period from initial SC event to
ost recent assessment (or death) was 2.3 2 years (range 0.1
o 7.1 years). To examine temporal trends in the presentation
f SC, we compared the 46 patients presenting during our early
xperience (August 2001 through February 2005), before the
ublication of 2 initial U.S. studies of SC (1,2), with our later
xperience of 90 patients (March 2005 through November
008).
MR imaging. At the discretion of the attending cardiolo-
ist, CMR imaging was performed in 95 patients shortly after
dmission. CMR was performed with a Siemens Sonata 1.5-T
canner (Siemens, Erlanger, Germany). Standard fast imaging
ith steady-state precision: inversion time  240 to 300 ms
also known as TrueFISP) cine images were acquired in 3
ong-axis slices and 11 to 15 short-axis slices, 7 mm in
hickness with a 3-mm interslice gap, achieving full ventricular
overage. A delayed enhancement protocol was employed 10
o 20 min after intravenous administration of gadolinium–
iethylenetriamine pentaacetic acid (0.2 mmol/kg) with
reath-hold inversion-recovery fast low-angle shot (Turbo-
LASH) or segmental TrueFISP sequences (8). Regional wall
otion was assessed using the 17-segment model of the LV
hamber (9).
ther testing. Ejection fraction (EF) was assessed on initial
dmission by LV angiography (n 100; 74%), 2-dimensional
chocardiography (n  34; 25%), CMR (n  1; 0.5%), and
T angiogram (n  1; 0.5%). At follow-up, EF was assessed
y echocardiography (n 76; 60%), CMR (n 49; 39%), and
V angiography (n  1; 1%). Left ventricular outflow tract
radients were measured with continuous-wave Doppler.
tatistics. SURVIVAL ANALYSIS. For those SC patients dis-
harged from the hospital after the initial event, the fraction
urviving at each follow-up time was estimated using the
aplan-Meier method (10). The expected fraction surviving
t each time after diagnosis was computed (10) by assigning
o each patient the probability of surviving after presenta-
ion, appropriate to patient age at diagnosis and sex, and
ased on U.S. Census data from Minnesota (11). Actual
nd expected surviving fractions were compared using the
-sample log-rank test, which also provides an estimate and
onfidence interval for the standardized mortality ratio and
Abbreviations
and Acronyms
CMR  cardiovascular
magnetic resonance
ECG  electrocardiogram
EF  ejection fraction
LV  left ventricle/
ventricular
RV  right ventricle/
ventricular
SC  stress cardiomyopathy5% confidence interval. All computations used the “sur- rival” package (version 2.34-1) of the R software system,
ersion 2.7.2R (Development Core Team 2008).
THER ANALYSES. Continuous measures are reported as
ean  SD and assessed with paired or unpaired Student t
est, as appropriate. Categorical measures were compared
ith standard chi-square test. GB-STAT statistical soft-
are, version 9.0 (Dynamic Microsystems, Silver Spring,
aryland) was used in analyses, and statistical significance
as defined as p  0.05. This investigation met the federal
egulatory requirements for exemption from institutional
eview board oversight and as such was granted a waiver
rom informed patient consent.
esults
linical features. PRESENTATION. At initial hospitaliza-
ion, the 136 patients with SC events were 32 to 92 years of
ge (mean age 68  13 years), 13 (10%) were 50 years of
ge, 130 (96%) were women, and 6 (4%) were men (Figs. 1
o 4). The most common presenting cardiovascular symp-
oms were substantial chest pain (n  85; 63%), exertional
yspnea (n  25), and syncope (n  4). Two other patients
resented to the hospital in asystole or ventricular fibrilla-
ion (1 of whom survived). The remaining 20 patients with
C were identified during the management or monitoring
f noncardiac conditions.
In 121 patients (89%), careful history-taking identified
ignificant stressful events immediately preceding (within
bout 12 h) the presentation of SC under diverse circum-
tances (Table 1). These events were regarded as emotion-
lly mediated in 64 patients (47%), usually involving per-
onal or family life crisis events, or alternatively due to a
hysical trigger in 57 (42%), most commonly acute noncar-
iac illness (n  36) or a medical/surgical procedure or
iagnostic test (n  9). These circumstances are detailed in
able 1.
Among the patients with physical triggers, exposure to
atecholamine and beta-agonist drugs in doses routinely
dministered in clinical practice were disproportionately
ssociated with SC events (n  13), including: inhaled
lbuterol or salmeterol for acute respiratory failure (n 
0, including 1 each with subcutaneous epinephrine or
opamine), intravenous dobutamine during stress echo-
ardiography (n  1) and phenylephrine for hypotension
uring spinal surgery (n  1), and intranasal phenyleph-
ine for unrelenting epistaxis (n  1). In the remaining
5 (11%) study patients (age 73  14 years; 14 women),
stress trigger could not be elicited, despite repeated
uestioning.
EDICATIONS. Of the 136 SC patients, 58 were taking
ardioactive drugs for control of blood pressure at the time of
heir event either alone or in combination, including beta-
lockers (n  25), angiotensin-converting enzyme inhibitors
n  24), calcium channel blockers (n  12), angiotension-II
eceptor blocker (n  11), and clonidine (n  3).
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January 26, 2010:333–41 Clinical Profile of Stress CardiomyopathyEX. Clinical presentation and demographics of SC did not
iffer between male and female patients. At the time of their
nitial SC event, the 6 male patients were 65  15 years of
ge, predominantly experiencing physical triggers (n  4).
he 130 women were 68  13 years of age (p  0.63 vs.
en) at the time of their event, predominantly with emo-
ional triggers (n  63).
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Figure 1 Ages at Stress Cardiomyopathy Presentation, by Sex
Ages at initial stress cardiomyopathy event, shown separately by sex.
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Figure 2 Clinical Course and History of Patients With Stress C
Flow diagram showing clinical course and natural history of 136 patients with streCG and biomarkers. On admission, ST-segment eleva-
ion mimicking acute anterior myocardial infarction was the
ost common electrocardiogram (ECG) finding, occurring in
7 patients (49%). The ECG findings in the remaining 69
atients without ST-segment elevation were diverse and in-
luded: diffuse T-wave inversion (n  22; 16%), healed
nterior infarction (n  26; 19%); nonspecific (n  17; 13%);
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Clinical Profile of Stress Cardiomyopathy January 26, 2010:333–41eft bundle branch block (n  2; 1%); or normal (n  2, 1%).
n admission, troponin T was elevated in 125 patients (92%),
.6  1.8 ng/ml (range 0.01 to 5.2 ng/ml), and peak in-
ospital troponin release was 0.6  0.7 ng/ml (range 0.01 to
.2 ng/ml). No relation was evident between ECG pattern,
roponin level, clinical features and outcome, or LV contrac-
ion pattern.
MR imaging. LV contraction abnormalities characterized
y CMR imaging (n 95) showed substantial variability with
espect to the patterns of akinesis/dyskinesis and ventricular
allooning including: 1) combined mid-ventricular and distal
apical) LV (n  72); 2) mid-LV only (n  16); 3) distal
apical) LV only (n  7) (Fig. 3). Right ventricular (RV)
kinesia was also present in 23 patients, associated only with
he mid-LV (n 5) and combined mid- and distal LV contrac-
ion patterns (n  18) (Fig. 4). Patients with RV contraction
bnormalities had lower LV ejection fraction (26 8%) than did
atients with normal RV contractility (32 11%; p 0.003).
o relation was evident between LV or RV contraction
atterns and clinical presentation, mortality, age, sex, ECG
A B
C D
E F
Figure 3 Diversity of LV Contraction Patterns in SC, as
Demonstrated by CMR in Vertical Long-Axis View
(A, C, and E) Diastole; (B, D, and F) systole. Three types are depicted: (A, B)
most common pattern of mid and apical left ventricular (LV) akinesia (arrow-
heads); (C, D) mid-LV akinesia (arrowheads) with sparing of apical region; and
(E, F) apical LV contraction abnormality only (arrowheads). CMR  cardiovas-
cular magnetic resonance; SC  stress cardiomyopathy.attern, peak troponin, and type of stress trigger. 4Of the 79 patients with abnormal contraction involving
he distal portion of the LV chamber, 33 nevertheless
howed localized sparing of the most apical segment (i.e.,
17 in the American Heart Association model) (9). Only 1
tudy patient (a 51-year-old woman) showed delayed en-
ancement consistent with scarring of the distal LV, not
ypical for myocarditis (12), and associated with the highest
eak troponin value (i.e., 5.2 ng/ml).
cute management and complications. OUTCOME. Three
atients (2%) died in the acute phase during hospitalization,
ncluding 1 from cardiogenic shock (age 92 years) despite
ggressive supportive therapy with inotropic drugs (Fig. 2).
he second patient (age 58 years) died of anoxic brain injury
fter cardiac arrest and mechanical ventilation, and the third
age 89 years) of traumatic intracerebral hemorrhage.
Intraventricular apical thrombi were identified in 5 pa-
ients (4 in LV and 1 in both LV and RV), and by CMR in
of these including the RV thrombus (Fig. 4). Of the 5
atients, 2 experienced embolic events: cerebral in 1 and
oth cerebral and pulmonary in 1. Three of these 5 patients
ere treated with warfarin with no subsequent events. In
ddition, 13 patients developed dynamic obstruction to LV
utflow (gradients, 54 48 mm Hg) due to systolic anterior
otion of the mitral valve and mitral-septal contact, and in
patients, following the intravenous administration of
notropic agents for hypotension (Fig. 4). In each, outflow
bstruction resolved and 12 patients survived.
JECTION FRACTION. On admission, EF was 32  11%
range 15% to 55%). Of the 136 patients, 131 (96%) had at
east 1 follow-up EF determination and 126 of these had
ventual return to normal ejection fraction (50%). Of the 126
atients, at first follow-up (in-hospital after 3.3  3.4 days or
ost-discharge after 51  52 days), 94 had EF within
ormal limits (mean 54  11%), but in 32 it remained
50%. Of these latter 32 patients, 26 had normal EF
ubsequently at 76  137 days after discharge (i.e., 59 7%).
Six other patients (5%) (age 76  7 years with initial EF
nly 26  7%), showed delayed EF normalization (57 
%) over at least 2.5 months and up to 12 months following
heir event.
In 5 of the 131 patients, follow-up EF determination
erformed in-hospital (range 1 to 13 days) demonstrated
mprovement from 26  11% to 40  4%, p  0.05, but
one achieved normal range, however, and later EF deter-
inations were not performed.
ollow-up. SURVIVAL. Of the 136 patients, 116 (85%) have
urvived over the follow-up period since their SC event for
.9  2 years (range 0.1 to 7.4 years, mean age 69  13
ears) (Figs. 2 and 5); 110 were women and 6 were men. Of
hese 116 survivors, 44 (38%) have achieved age 75 years.
Seventeen other patients (15%) died after hospital dis-
harge at age 51 to 92 years (mean age 73  12 years), all
rom noncardiac causes, most commonly cancer (Fig. 2).
he interval from initial SC event to death was 4 months to
.7 years (mean 1.3  1.5 years).
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January 26, 2010:333–41 Clinical Profile of Stress CardiomyopathyWhen analyzed for all-cause mortality, survival of the
tudy patients with SC after their initial event was signifi-
antly reduced compared with that expected in an age- and
ex-matched general population from Minnesota (p 
.016; standardized mortality ratio: 1.7; 95% confidence
nterval [CI]: 1.1 to 2.7) (Fig. 5). The excess in mortality for
C patients occurred predominantly in the first year after
iagnosis (including 9 patients who died of cancer, 4 with
C events linked to their malignancy).
The standardized mortality ratio during the first year after
iagnosis was 6.8 (95% CI: 4.0 to 11.5), whereas during
ubsequent years, the standardized mortality ratio was 0.6 (95%
I: 0.3 to 1.4; p  0.0001, comparing 1 year vs. 1 year).
ECURRENCES. Seven patients (5%, all women) experi-
nced additional nonfatal SC episodes at age 51 to 85 years
mean age 66 years) (Table 2, Fig. 2); 6 of these had 1 SC
vent recurrence 3 weeks to 3.8 years after the first (includ-
ng 1 with ventricular fibrillation) and the other patient
xperienced 3 SC recurrences (0.8 to 4.4 years after the first
pisode). In 5 of the 7 patients with SC recurrences, the
nitial and subsequent events involved similar stress triggers
Figure 4 Additional Abnormalities in SC Demonstrated by CMR
(A, B) In this horizontal long-axis image, right ventricular (RV) free wall akinesia (w
with typical mid- and apical LV akinesis (white arrowheads). (C) In the short-axis
responsible for pulmonary embolization, are evident. From the same patient shown
motion (SAM) and mitral-septal contact, following administration of an inotropic ag
(arrowheads). Abbreviations as in Figure 3.either emotional [n  4] or physical [n  1]), and in 4 of the 5 the circumstances of the events were similar or
irtually identical.
Three of these 7 patients were taking beta-blocking
gents at the time of their first recurrent SC event, and the
atient with 3 recurrences was taking beta-blockers on the
ccasion of each event. No clinical or demographic feature
istinguished the patients with recurrent SC from the other
tudy patients.
EMPORAL TRENDS. During the 7.4 years of this study, the
umber of SC diagnoses increased from 46 patients (34%)
uring the first 3.6 years to 90 patients (66%) during the
ater 3.8 years. This was associated with a shift in the
redominant stress trigger from emotional (32 of 46 [70%]),
o physical (44 of 90 [49%]; p  0.0004).
iscussion
he present large series of prospectively identified patients
ith SC from a single institution describe an expansive clinical
rofile during acute presentation and also provides additional
nsights into the natural history of this cardiomyopathy. The
rrows) is evident in systolic (B) compared with diastolic (A) and is associated
eft ventricular thrombus (LVT), and a right ventricular thrombus (RVT), which was
and B. (D) Dynamic obstruction to LV outflow produced by systolic anterior
r hypotension. A mid- and apical LV contraction abnormality is also presenthite a
view, l
in A
ent foypical SC patient has been characterized as an older woman
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Clinical Profile of Stress Cardiomyopathy January 26, 2010:333–41xperiencing an intensely stressful event that acts as a trigger
or acute, but reversible, heart failure with systolic dysfunction
13–16). However, based on our data, the clinical profile of SC
s considerably broader, with an important minority of patients
elatively young (50 years of age; range to 32 years) or men.
lso, unexpectedly 11% of patients related no emotional or
hysically stressful event immediately before hospitalization,
espite demonstrating typical angiographic and ECG features
xamples of Emotional and Physical Stressorsriggering Heart Failure i SC PatientsTable 1 Examples of Emotional and Physical StressorsTriggering Heart Failure in SC Patients
Emotional (n  64)
Anger/frustration (n  10)
Heated argument with family members, friend, or landlord over rent
Frustration regarding work environment or personal property
Argument with husband (afflicted by dementia)
Frustration related to organizing a community event
Related to financial or employment problems (n  7)
Gambling loss including passing bad checks
Personal business failure with loss of life savings
Recognition of large business debt
Stress during meeting with management at work
Stressful beginning to a new job
Grief/loss (n  18)
Notification of recent sudden death in a close relative or friend
Tenth anniversary of son’s death
Cardiac arrest in husband (patient performed cardiopulmonary resuscitation)
Husband with post-operative cardiac arrest and anoxic encephalopathy
Multiple deaths of family members in close proximity
Advised of son’s death in military
Sense of loss after retiring from life-long occupation
Impending death of husband from cancer
Expressing grief at memorial service for public figure (U.S. senator)
Death of 2 pet dogs
Reflecting on death of son-in-law during church meeting
Interpersonal conflict (n  14)
Lengthy divorce culminating in sale of her home of 28 years
Separation from husband
Severe depression with suicidal ideation
Failure to keep up with daughter during bicycle race
Discussing family estrangement during psychological counseling
Discussing brother’s methamphetamine addiction and alcoholism
Relocation of permanent residence
Physical domestic abuse by spouse
Estrangement from daughter
Overwhelming emotion during 50th wedding anniversary
Informed that best friend was moving a great distance
Upsetting phone call from friend
Sexual abuse by relative
Panic/fear/anxiety (n  15)
Accidental fall outdoors in winter with hip fracture (feared freezing to death)
Flat tire while driving a remote road in Minnesota (without cell phone)
Legal deposition regarding motor vehicle accident
Lost while driving in unsafe neighborhood at night
Overwhelmed by new computer software at work
Lost with flat tire while driving mother to physician
Poultry barn burned down (fearing loss of chickens)
Anxiety regarding a public speaking event
Sudden illness of husband
Basement flood during intense thunderstorm
Anxiety about elevated blood pressure/paroxysmal atrial fibrillation
Anxiety about elective cardioversion for atrial fibrillation
Panic while trying to load belongings into car during bitter cold
Fall at home while alone with fear of not being found
Fall at home with hip fracture; unable to call help
Panic attack during lung biopsy for suspected malignancy
Continuedf this condition (17–19). This latter observation has implica- nions for both the nomenclature and pathophysiology of this
ondition. Indeed, the descriptive term used here and com-
only in the literature, stress cardiomyopathy (13,17,20,21),
oes not reliably describe all affected patients with this syn-
rome, each of whom do in fact demonstrate transient ven-
ricular ballooning.
A multitude of specific triggers preceded SC events, most
ommonly emotion-mediated. However, we found the fre-
uency of physically related stressors was high (i.e., 43%),
articularly with the administration of certain pharmaco-
ogic agents. For example, the use of beta-agonist broncho-
ilator drugs contributed to heart failure onset in some
atients with acute respiratory failure from chronic obstruc-
ive pulmonary disease or asthma. In other patients, admin-
stration of exogenous catecholamines (i.e., phenylephrine,
ontinuedTable 1 Continued
Physical (n  57)
Acute respiratory failure (n 15)
Exacerbation of chronic obstructive pulmonary disease*
Pulmonary embolism
Laryngeal obstruction from neoplasm
Respiratory distress from influenza
Acute epiglottitis requiring intubation
Central nervous system conditions (n  10)
Subarachnoid hemorrhage
Brain contusion from accidental fall
Ruptured cerebral aneurysm
Vasculitis
Migraine headache
Seizure
Brain abscess
Malignancy† (n  6)
Advanced or metastatic cancer
Chemotherapy for metastatic colon or esophageal cancer
Metastatic carcinoid tumor
Infection (n  3)
Urosepsis
Spinal fusion wound infection
Peritonitis from ischemic bowel
Post-surgical/fracture (n  8)
Hysterectomy and bilateral oophorectomy
Knee arthroplasty
Discectomy and T12-S1 fusion for scoliosis‡
Cholecystectomy
Decompression of spinal stenosis
Pericardicentesis
Hip fracture
Other (n  15)
Nosebleed treated with phenylephrine
Accidental home insulin overdose
Intentional Phenergan overdose
Dobutamine stress test
Gastrointestinal bleeding/gastroenteritis with dehydration
Acute rejection of renal transplant
Diabetic/nondiabetic gastroparesis
Anorexia with profound weight loss
Allergic drug reaction
Prolonged viral illness/dehydration
Hypertensive crisis
Withdrawal from alcohol
11 total cases. †Linkage of stress cardiomyopathy (SC) and cancer was established if onset of
vent was directly due to symptoms from the malignancy, chemotherapy, or initially learning of the
iagnosis. ‡SC was recognized clinically during general anesthesia.orepinephrine, or dobutamine [during routine stress test-
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January 26, 2010:333–41 Clinical Profile of Stress Cardiomyopathyng]) appeared to trigger SC (21). Finally, SC occurred in 1
atient who was unconscious during general anesthesia,
hich suggests an autonomic nervous system mechanism.
Taken together, these observations underscore the im-
ortance of heightened index of suspicion for SC in com-
on clinical circumstances such as routine medical or
urgical procedures, administration of drugs, and standard
iagnostic testing (22,23). However, the dramatic presen-
ation of SC in response to such common provocations is
xceedingly rare overall.
Five percent of our surviving study patients experienced
ecurrent and remarkably similar SC episodes (usually emo-
ional), demonstrating a unique propensity for stress-triggered
eart failure and systolic dysfunction. The explanation for this
eculiar susceptibility to SC remains elusive. Nevertheless,
hese observations underscore the importance of educating
atients regarding the small but real risk of SC recurrence and
he value of lifestyle modification to avoid exposure to identi-
able emotional or physical stressors.
SC has been regarded as a largely reversible form of acute
eart failure associated with LV remodeling and systolic
ysfunction. However, our experience underscores that SC
s not entirely benign, as about 5% of patients experienced
ither cardiac arrest (and survived) or died during hospital-
zation despite appropriate aggressive treatment (24). That
ome patients do not survive their acute SC event only
nderscores the importance of prompt recognition and
argeted management with respect to systemic hypotension,
entricular tachyarrhythmias, dynamic LV outflow obstruc-
0 500 1000
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0
0.
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Figure 5 Kaplan-Meier Survival Curves for Stress Cardiomyopat
Kaplan-Meier survival curves for 136 patients with stress cardiomyopathy (solid re
expected in an age- and sex-matched general population from Minnesota (brokenion, and ventricular thrombi. pThe inference from the assembled literature is that LV
ontraction abnormalities and systolic dysfunction in SC
niformly normalize rapidly at or before hospital discharge
13–16). However, we found evidence in an important
inority of patients for a considerable delay in this process.
hereas 95% of patients ultimately showed follow-up EF
alues 50%, normalization was delayed for 2.5 to 12
onths in 5% of patients.
The clinical course following SC events after hospital
ischarge is incompletely defined. Notably, our follow-up
nalysis showed that the survival of SC patients was reduced
ompared to that expected for an age- and sex-matched
eneral population; in each case, mortality was due to
oncardiac diseases (predominantly cancer), most frequently
n the first year following the initial SC event. These data
uggest that SC itself may represent a marker for generally
mpaired health and well-being, albeit in contrast to an earlier
eport (19). On the other hand, fully one-third of our patients
ho survived their initial event have achieved normal life
xpectancy (i.e., age 75 years).
During the most recent years, the number of identified
ases increased dramatically with two-thirds enrolled in
he last 50% of the study period, which was associated
ith a shift in the predominant stressor from emotional
o physical.
Because of the potential role that catecholamines and
xcessive sympathetic stimulation play in the pathophysiol-
gy of this condition, as suggested here and by other
nvestigators (2,21), hypothetically, beta-blocking drugs
ould be expected to provide a measure of pharmacologic
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bsolutely prevent either the first or recurrent SC episodes;
n other words, 20% of these events occurred while beta-
lockers were administrated. Within our observational study
esign it was not possible to determine whether cardioactive
rugs provided relative risk reduction for SC.
Our observations have certain other management impli-
ations. For example, the dyskinetic/akinetic ventricular
egments can provide the structural basis for intracavitary
hrombus formation. A small proportion of our patients had
ntraventricular thrombi (while in sinus rhythm), with or
ithout disabling thromboembolic events suggesting a po-
ential protective role decided on a case-by-case basis for
rophylactic warfarin anticoagulation. In addition, CMR
dentified ventricular thrombi not visualized by echocardi-
graphy, underscoring the important diagnostic contribu-
ion of this imaging modality in SC.
Furthermore, using CMR, we observed a diversity of
ontraction patterns during the acute phase of SC, under-
coring the peculiar vulnerability of both right and left
entricles in this condition (25–27) (Figs. 3 and 4). Expect-
dly, akinesia/dyskinesia most commonly involved both the
atients With Recurrence of SCTable 2 Patients With Recurrence of SC
Patient # Event
Age (yrs)/
Sex
Interval from
Initial Event Drugs at SC Event
1 Initial* 51/F — Premarin
Recurrence 1 51 3 weeks Diltiazem nitroglycerin (
2 Initial 53/F — Estrace
Recurrence 1 55 1.2 yrs Estrace
3 Initial 53/F — Verapamil
Estratest
Recurrence 1 54 0.8 yrs Atenolol
Lisinopril
Estraderm
Recurrence 2 54 1.5 yrs Carvedilol
Amlodipine
Lisinopril
Estraderm
Recurrence 3 57 4.4 yrs Carvedilol
Amlodipine
4 Initial 65/F — Enalapril
Digoxin
Recurrence* 68 2.9 yrs Metoprolol
Enalapril
Digoxin
5 Initial 66/F — None
Recurrence 1 70 3.8 yrs None
6 Initial 78/F — None
Recurrence 1 79 1.1 yrs Metoprolol
7 Initial 83/F — Clonidine and flecainide
Recurrence 85 2.3 yrs Digoxin
Clonidine
Isordil
Presentation in ventricular fibrillation. †Flecainide administered for symptomatic premature ven
E emotional; ECG electrocardiogram; EF  ejection fraction; IV  intravenous; MImyoca
achycardia.id- and apical portions of LV in about 75% of patients e4,5,13). However, the remaining 25% of patients showed
egmental contraction abnormalities confined to either mid-
28) or apical LV. Our latter small subgroup with akinesia
onfined to the distal LV is distinctive from the generally
ecognized patterns in this condition (13–16), although
ach of these patients had a clinical profile otherwise
onsistent with SC. Finally, a sizable minority of our
atients also showed more diffuse cardiac involvement with
kinesia of the RV wall (26,27). We did not encounter SC
atients with abnormal contraction limited to the basal LV,
s reported by other investigators (20,29).
onclusions
his consecutive series of SC patients represents the largest
ohort reported to date in detail, demonstrating a clinical
eterogeneity perhaps not widely appreciated. In this re-
ard, small but important subsets of patients (together
omprising 35% of the overall study population) were
dentified with either male sex, relatively youthful onset
50 years, in-hospital death, nonfatal recurrent SC events,
bsence of a stress trigger, and delay in normalization of
Stressor
% EF
(Admission) ECG Stress Trigger
E 15 STE Reflecting on brother’s death and
ordeal of incest
E 65 STE Same
E 30 T-inversion Death of 4 family members within a short
period of time, including both parents
E 40 Normal Family conflict over execution of wills
E 15 STE Lost while driving at night
E 25 Healed MI Discussing family during
psychotherapist session
E 25 Healed MI During discussion of anxiety related
to SC events
E 20 Healed MI Discussing divorce of daughter
E 30 Nonspecific Heated argument over father’s death
None 25 Nonspecific Stressor absent
E 30 Nonspecific Gambling loss/passing bad checks
E 35 Nonspecific Conflict at home over relationships
P 30 STE Accidental fall with brain contusion
P 35 STE Accidental fall with subdural hematoma
P† 40 Nonspecific Sustained VT induced by flecainide
E 20 STE Flat tire while driving alone
beats, appeared to trigger wide-complex monomorphic VT and marked systemic hypertension.
arction; P  physical; SC stress cardiomyopathy; STE  ST-segment elevation; VT  ventricularIV)
tricularjection fraction. Beta-blocking drugs in standard dosages
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January 26, 2010:333–41 Clinical Profile of Stress Cardiomyopathyand other cardioactive drugs) failed to provide absolute
rotection against either initial or recurrent SC events, and
herefore have an unproven benefit in this condition. Oc-
urrence of intraventricular thrombi (and embolic stroke)
hould raise consideration for prophylactic anticoagulation
n some patients.
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